AI in Medicine News — 2026-10-15 (Thu) Evening News

Overview

Regulation and oversight drew the most coverage: Britain's MHRA, the FDA, and several oversight and ethics frameworks. Imaging and emergency AI products expanded, and the AI drug discovery sector saw an IPO and several platform announcements. Headlines mostly do not state accuracy figures or the stage of evidence, so efficacy cannot be assessed from this material.

Diagnostics and imaging

- ThinkSono secured FDA clearance for ultrasound AI software for blood clots (Medical Product Outsourcing). The headline gives no performance figures. - An AI tool improves diagnosis of rare bone and soft tissue tumors (Technology Networks). The headline gives no accuracy figures or study stage. - A large prostate MRI study examines AI and unassisted radiologist assessment (Diagnostic Imaging). The headline does not state the findings. - Coreline Soft expanded its emergency AI portfolio beyond brain hemorrhage to pulmonary embolism, aortic disease and fractures (Korea IT Times). - Radiology Business published a 3-step buyer's guide for evaluating radiology AI solutions (Radiology Business). - A Houston emergency physician discussed the role of AI in emergency medicine (The Detroit News).

Clinical decision support

- Nature published a Nature Medicine series on real-world clinical AI deployment (Nature). - The CEO of Centene said Medicaid patients are the last to benefit from innovation and that AI can change that (Fortune). - Healthcare Today ran a piece on why the source behind an AI answer matters (Healthcare Today). - Nikkei Medical ran a piece asking whether to order additional tests when generative AI suggests a rare disease (Nikkei Medical). 【Generative AI and clinical documentation】 No notable developments. 【Hospital operations and care delivery】 - Singapore General Hospital uses AI to speed up brain bleed detection (Healthcare Asia Magazine). - KPJ Healthcare introduced AI-assisted colonoscopy at Johor Specialist Hospital to support early colorectal cancer detection (KLSE Screener). - NHS England-related material includes an "NHS Communications Artificial Intelligence Operating Framework v2" (The NHS Alliance). - Rotherham, Doncaster and South Humber NHS Trust reported that AI is transforming how mental health clinicians support local people (Rotherham, Doncaster and South Humber NHS Trust). - Metalabs is partnering with a Chinese robot firm to push AI hair transplant in Korea (Chosunbiz). 【Drug discovery and clinical trials】 The headlines do not state development stages (preclinical, Phase I, etc.). - Iambic, an AI drug discovery specialist, banked $150M in an IPO (BioPharma Dive). - Insilico Medicine recapped its Pharma.AI Fall 2026 release, citing specialized models and AI agents for drug discovery and development (Insilico Medicine). - WCG unveiled an AI-powered solution to accelerate clinical trial kickoffs (Fierce Biotech). - BioAge Labs and Deep Origin are collaborating on AI-driven drug discovery (Moomoo). - An economist said "China shock 3.0" will be driven by AI, biotech and robot exports (South China Morning Post). 【Medical device approval and regulation】 - ThinkSono's ultrasound AI software for blood clots received FDA clearance (Medical Product Outsourcing). - MHRA announced a strategy to streamline regulation in the AI era (RAPS), and plans continuous monitoring of AI medical devices (Medical Buyer). - The UK accepted 44 healthcare AI reforms; new rules remain pending (Quasa.io). - The FDA clarified its rules for medical AI (Streetwise Reports). The headline does not say which document or instrument. - DigitalEurope published a piece on moving towards a single regulatory pathway for AI-enabled medical technologies (DigitalEurope). - PharmTech.com discussed how AI can assist with postmarketing changes (PharmTech.com).

Safety, errors and bias

- A new framework measures the human oversight gap in cardiology AI (Bioengineer.org). - A new ethical framework maps how medical AI diagnostics must behave (Bioengineer.org). - A human rights test for medical AI covers safety, fairness and accountability, with regulators drawing the line on patient safety and clinical control (GeneOnline). - MHRA plans continuous monitoring of AI medical devices (Medical Buyer). - Euronews published a piece on AI in healthcare, from fighting epidemics to family doctors (Euronews.com). 【Research findings (major journals)】 - A study found most patients will not endorse AI medical responses without a clinician's review (Medical Xpress). A related report said patients would rather wait for a clinician's review than get an instant AI answer to medical questions (Medical Economics). The headlines do not give sample sizes or the journal. - An AI platform lets patients communicate with their medical devices (The Washington Post, healthcare-in-europe.com). The headlines do not state the evidence stage.

Developments in Japan

- GENSHI AI released GENSHI-MedQA-1M, a Japanese medical QA dataset of over 1 million items, described as the world's largest-scale Japanese-text medical QA dataset (PR TIMES). - Philips released its global survey report "Future Health Index 2026," saying AI is moving from possibility to practice and that concrete results are starting to appear in clinical settings (Innavi Net). - Nikkei Medical asked whether to order additional tests when generative AI suggests a rare disease (Nikkei Medical). - NinjaOne's "Katana AI" (IT Leaders) and an AI home inspection service (DX Magazine) were also collected but are outside healthcare.

Statements by key figures

- The CEO of Centene said Medicaid patients are the last to benefit from innovation and that AI can change that (Fortune).